Open an account

Clarivate

CLVT · NYSE

$1.78+$0.02 (+1.14%)TodayMarket closed ·
Prev close $1.76

About CLVT

Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. The firm offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company offers solutions across various areas, which include scientific and academic research, information solutions and library software. Its ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats, including data bases, dissertations, news, primary sources, books, and video. Within the IP segment, the Company provides IP data, software, and expertise to other companies to manage and protect critical IP assets. This segment's service offerings include IP management software, Patent services and Brand IP solutions, among others. Within the LS&H segment, the Company offers solutions across research and development, commercial and Medtech.

Employees
12,000
Headquarters
London, Pennsylvania
Listed
Oct 29, 2018
Sector
Industrials
Industry
Professional Services
Website
clarivate.com

CLVT key statistics

Market cap
1.14B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
3.64M
Volume
2.86M
Open price
$1.80
High today
$1.85
Low today
$1.77
52 Week high
$3.87
52 Week low
$1.42

Clarivate (CLVT) at a glance

Clarivate (CLVT) last traded at $1.78, with a market cap of 1.14B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.77 and $1.85. The current price is 0.8% above the day's low and 3.8% below its high.

Volume so far is 2.86M shares, below the average of 3.64M shares a day.

Over the past year Clarivate has ranged from $1.42 to $3.87, and now sits 15% of the way up that range.

Clarivate met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $0.19 per share against an estimate of $0.1846.

The average analyst price target is $2.94, 65.2% above the current price, from 6 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

17%of 6 analyst ratings say Buy
  • Buy16.7%
  • Hold50.0%
  • Sell33.3%
Price target · 8 analystsAvg $2.94
Low
$2.02
Now
$1.78
High
$5.25

CLVT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 9.3% on average.

  1. Q3 FY24: reported $0.19 per share against an estimate of $0.1896
  2. Q4 FY24: reported $0.21 per share against an estimate of $0.2067
  3. Q1 FY25: reported $0.14 per share against an estimate of $0.1183
  4. Q2 FY25: reported $0.18 per share against an estimate of $0.1769
  5. Q3 FY25: reported $0.18 per share against an estimate of $0.1649
  6. Q4 FY25: reported $0.20 per share against an estimate of $0.1692
  7. Q1 FY26: reported $0.18 per share against an estimate of $0.1477
  8. Q2 FY26: reported $0.19 per share against an estimate of $0.1846

CLVT news

  • Press releaseBusiness Wire

    Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions

  • Press releasePRNewswire

    Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation

  • Press releasePRNewswire

    Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

  • Press releasePRNewswire

    Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

  • Press releasePRNewswire

    Clarivate to Report Third Quarter 2026 Results on November 3, 2026

  • Press releasePRNewswire

    Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

  • Press releasePRNewswire

    Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs

  • Press releasePRNewswire

    Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.